ROLE OF CYTOCHROME-P-450 EPOXYGENASE METABOLITES IN EGF SIGNALING IN RENAL PROXIMAL TUBULE

被引:38
作者
BURNS, KD
CAPDEVILA, J
WEI, SZ
BREYER, MD
HOMMA, T
HARRIS, RC
机构
[1] DEPT VET AFFAIRS MED CTR, NASHVILLE, TN 37232 USA
[2] UNIV OTTAWA, DEPT MED, OTTAWA, ON K1H 8M5, CANADA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY | 1995年 / 269卷 / 04期
关键词
EPOXYEICOSATRIENOIC ACIDS; CALCIUM; MITOGENESIS; KIDNEY; EPIDERMAL GROWTH FACTOR;
D O I
10.1152/ajpcell.1995.269.4.C831
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Epidermal growth factor (EGF) is a potent epithelial cell mitogen and induces eicosanoid production in many cell types. The present study examined signaling mechanisms for EGF in the renal proximal tubule, where high concentrations of cytochrome P-450 epoxygenase have been reported. In primary cultures of rabbit proximal tubule cells, EGF (30 nM) increased endogenous epoxyeicosatrienoic acid (EET) levels 5.3 +/- 1.4-fold within 10 min (n = 6). In these cells EGF-stimulated [H-3]thymidine incorporation was significantly inhibited by the cytochrome P-450 inhibitors ketoconazole or clotrimazole but not by the cyclooxygenase inhibitor indomethacin. In fura 2-loaded proximal tubule cells, EGF caused a concentration-dependent increase in cytosolic Ca2+ concentration ([Ca2+](i)), due to Ca2+ influx, which was inhibited by either ketoconazole or SKF-525A but not by indomethacin. Addition of 5,6-EET (0.5 mu M) also induced Ca2+ influx in proximal tubule cells, whereas 8,9-,11,12-, or 14,15-EET did not. In cells treated with bis(2-amino-5-methylphenoxy)ethane N,N,N ', N'-tetraacetic acid tetraacetoxy-methyl ester to chelate [Ca2+](i), EGF-stimulated [H-3]thymidine incorporation was significantly inhibited. Pretreatment of cells with 5.6-EET also augmented EGF-stimulated [H-3]thymidine incorporation. These results indicate that EGF increases EET levels in proximal tubule and suggest that 5,6-EET or its metabolites may be a modulator of EGF-induced[Ca2+](i) increases and involved in mitogenesis.
引用
收藏
页码:C831 / C840
页数:10
相关论文
共 54 条
  • [1] AGONIST-INDUCED CA2+ INFLUX INTO HUMAN PLATELETS IS SECONDARY TO THE EMPTYING OF INTRACELLULAR CA2+ STORES
    ALONSO, MT
    ALVAREZ, J
    MONTERO, M
    SANCHEZ, A
    GARCIASANCHO, J
    [J]. BIOCHEMICAL JOURNAL, 1991, 280 : 783 - 789
  • [2] CYTOCHROME-P-450 MAY LINK INTRACELLULAR CA2+ STORES WITH PLASMA-MEMBRANE CA2+ INFLUX
    ALVAREZ, J
    MONTERO, M
    GARCIASANCHO, J
    [J]. BIOCHEMICAL JOURNAL, 1991, 274 : 193 - 197
  • [3] INOSITOL PHOSPHATES AND CELL SIGNALING
    BERRIDGE, MJ
    IRVINE, RF
    [J]. NATURE, 1989, 341 (6239) : 197 - 205
  • [4] INOSITOL TRISPHOSPHATE, A NOVEL 2ND MESSENGER IN CELLULAR SIGNAL TRANSDUCTION
    BERRIDGE, MJ
    IRVINE, RF
    [J]. NATURE, 1984, 312 (5992) : 315 - 321
  • [5] SEGMENTAL SYNTHESIS AND ACTIONS OF PROSTAGLANDINS ALONG THE NEPHRON
    BONVALET, JP
    PRADELLES, P
    FARMAN, N
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1987, 253 (03): : F377 - F387
  • [6] SEGMENTAL DISTRIBUTION OF EPIDERMAL GROWTH-FACTOR BINDING-SITES IN RABBIT NEPHRON
    BREYER, MD
    REDHA, R
    BREYER, JA
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1990, 259 (04): : F553 - F558
  • [7] EPIDERMAL GROWTH-FACTOR INHIBITS THE HYDROOSMOTIC EFFECT OF VASOPRESSIN IN THE ISOLATED PERFUSED RABBIT CORTICAL COLLECTING TUBULE
    BREYER, MD
    JACOBSON, HR
    BREYER, JA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1988, 82 (04) : 1313 - 1320
  • [8] REDUCTION OF EPIDERMAL GROWTH-FACTOR RECEPTOR AFFINITY BY HETEROLOGOUS LIGANDS - EVIDENCE FOR A MECHANISM INVOLVING THE BREAKDOWN OF PHOSPHOINOSITIDES AND THE ACTIVATION OF PROTEIN KINASE-C
    BROWN, KD
    BLAY, J
    IRVINE, RF
    HESLOP, JP
    BERRIDGE, MJ
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 123 (01) : 377 - 384
  • [9] INHIBITORS OF CYTOCHROME P-450-DEPENDENT ARACHIDONIC-ACID METABOLISM
    CAPDEVILA, J
    GIL, L
    ORELLANA, M
    MARNETT, LJ
    MASON, JI
    YADAGIRI, P
    FALCK, JR
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1988, 261 (02) : 257 - 263
  • [10] CAPDEVILA JH, 1991, METHOD ENZYMOL, V206, P441